A mutation in CYP2C9 is responsible for decreased metabolism of losartan.

• 1 February 1996
• journal article
• Published by Wiley in Clinical Pharmacology & Therapeutics
• Vol. 59  (2) , 215
• https://doi.org/10.1038/sj.clpt.1996.361

Abstract